Humanity faces disaster: antimicrobial resistance
Keywords:
Antimicrobial resistance, prevention, socioeconomic impact, ethics.Abstract
Introduction: Bacterial resistance endangers the health and survival of human beings and increases the economic burden on society and patients. It is a global phenomenon; therefore, Cuba is not exempted from it.
Objective: To present the social and economic impact of antimicrobial resistance from a philosophical point of view as well as to describe the role of a preventive measure to stop antimicrobial resistance.
Material and Methods: A review of bibliographic sources was carried out in databases such as PubMed and the Regional Portal of the Virtual Health Library; Google Scholar search engine was also used.
Development: Social, economic and ethical aspects related to bacterial resistance are analyzed. A preventive measure to stop antimicrobial resistance is described. In addition, the relationship between antibacterial drugs, bacterial resistance and prevention and control measures is analyzed from the point of view of science-technology-society.
Conclusions: Human society is constantly developing and progressing under the promotion of science and technology. In just a few decades, antibiotics have gone from being "miracle drugs of great impact on health" to being "a non-renewable resource in danger of extinction". Necessary measures such as the optimization of the use of antibiotics, a health policy support, and a health strategy for the prevention and control of infections must be taken to stop the development of bacterial resistance.
Downloads
References
1. Gualerzi CO, Brandi L, Fabbretti A, Pon CL. Antibiotics: targets, mechanisms and resistance [Internet]. Canada: British Library John Wiley & Sons; 2013 [Citado 03/11/2020]. Disponible: https://www.wiley.com/en-us/Antibiotics%3A+Targets%2C+Mechanisms+and+Resistance-p-9783527333059
2. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P & T : a peer-reviewed journal for formulary management [Internet]. 2015 [Citado 03/11/2020];40(4):277-83. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/
3. Sáenz J. Actualmente se ha estimado que podrían morir 10 millones de personas en el año 2050, si no se adoptan las medidas adecuadas [Internet]. Nueva York: Pfizer; 2018 [Citado 03/11/2020]. Disponible en: https://www.pfizer.es/noticia/actualmente_se_ha_estimado_podrian_morir_10_millones_personas_ano_2050_si_no_se_toman_medidas_adecuadas.html
4. Hurtado Amezquita YC, Rincón Plazas A, Padilla Acosta JC. Revisión sistemática: Factores asociados a colonización e infección por bacterias gram negativas resistentes a carbapenemicos [Tesis de Espeialidad]. Colombia: Universidad del Rosario; 2015 [Citado 03/11/2020]. Disponible en: http://repository.urosario.edu.co/handle/10336/10544
5. World Health Organization. Worldwide country situation analysis: response to antimicrobial resistance [Internet]. Geneva: WHO; 2015. [Citado 03/11/2020]. Disponible en: https://www.who.int/drugresistance/documents/situationanalysis/en/
6. Jackson LC, Machado L, Hamilton ML. Principios generales de la terapéutica antimicrobiana. Acta médica [Internet].1998 [Citado 03/11/2020]; 8(1):13-27. Disponible en: http://www.sld.cu/galerias/pdf/sitios/apua-cuba/a52-principios_generales_de_la_terapeutica_antimicrobiana.pdf
7. Belloso WH. Historia de los antibióticos. Rev Hosp Ital B Aires [Internet]. 2009 [Citado 03/11/2020];29:102-11. Disponible en: https://www1.hospitalitaliano.org.ar/multimedia/archivos/noticias_attachs/47/documentos/7482_102-111-belloso.pdf
8. Rincón S, Panesso D, Díaz L, Carvajal LP, Reyes J, Munita JM, et al. Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era. Biomedica [Internet]. 2014 [Citado 04/11/2020];34 (Suppl 1):191-208. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435674/
9. Quiñones Pérez D. Resistencia antimicrobiana: evolución y perspectivas actuales ante el enfoque "Una salud". Revista Cubana de Medicina Tropical [Internet]. 2017 [Citado 03/11/2020];69:1-17. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0375-07602017000300009&nrm=iso
10. Van TTH, Yidana Z, Smooker PM, Coloe PJ. Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses. Journal of Global Antimicrobial Resistance [Internet]. 2020 [Citado 03/11/2020];20:170-7. Disponible en: https://www.sciencedirect.com/science/article/pii/S2213716519301985
11. Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial Resistance. JAMA [Internet]. 2016 [Citado 03/11/2020];316(11):1193-204. Disponible en: https://doi.org/10.1001/jama.2016.11764
12. Sánchez Suárez BD. Determinantes para el uso de antibióticos según las actitudes y percepciones de Médicos Veterinarios en la producción avícola de Ecuador [Internet]. Quito: UCE; 2019 [Citado 03/11/2020]. Disponible en: http://www.dspace.uce.edu.ec/handle/25000/18750
13. Medina JG, Solorza IÁ, Tlachino MJGT, Miranda BR. Percepción de la resistencia bacteriana a antibióticos por el uso prolongado de antibióticos y automedicación en la población en general. En: XVI Coloquio Panamericano de Investigación en Enfermería [Internet]. La Habana: SOCUENF; 2018 [Citado 03/11/2020]. Disponible en: http://coloquioenfermeria2018.sld.cu/index.php/coloquio/2018/paper/view/1207
14. Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. Global geographic trends in antimicrobial resistance: the role of international travel. Journal Travel Medicine [Internet]. 2019 [Citado 03/11/2020];26(8):[Aprox. 2 p.]. Disponible en: https://academic.oup.com/jtm/article-abstract/26/8/taz036/5496989?redirectedFrom=fulltext
15. Wu Z, Trigo V. Views on Current Situation, Causes and Responses of Doctor-Patient Conflicts in New Situations. En: 4th International Seminar on Education, Management and Social Sciences (ISEMSS 2020) [Internet]. Netherlands: Atlantis Press; 2020 [Citado 03/11/2020]. Disponible en: https://www.atlantis-press.com/proceedings/isemss-20/125944121
16. Pulido Sánchez S. Vigilancia del estado de portador de bacterias multirresistentes [Tesis de Especialidad]. España: Universidad Complutense; 2017 [Citado 03/11/2020]. Disponible en: https://eprints.ucm.es/id/eprint/55151/
17. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clinical Infectious Diseases [Internet]. 2006 [Citado 03/11/2020]; 42(Suppl 2):S82-S9. Disponible en: https://doi.org/10.1086/499406
18. Ling L, Weixuan W, Shumei S, Hao Z, Fang Y. Systematic evaluation on direct economic burden of healthcare associated infecction due to multidrug resistant organisms. Chin J Infect Control [Internet]. 2017 [Citado 03/11/2020];16:616-21. Disponible en: https://kns.cnki.net/KXReader/Detail?dbcode=CJFD&filename=GRKZ201707006&uid=WEEvREcwSlJHSldTTEYzWEpEYnlOcHFPY2QrUXhaVUN2S1F3V2dYZG5QZz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw
19. Otter JA, Burgess P, Davies F, Mookerjee S, Singleton J, Gilchrist M, et al. Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective. Clinical Microbiology Infectious Diseases [Internet]. 2017 [Citado 03/11/2020];23(3):188-96. Disponible en: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)30464-5/fulltext
20. Troncoso C, Pávez M, Santos A, Salazar R, Barrientos L. Implicaciones estructurales y fisiológicas de la célula bacteriana en los mecanismos de resistencia antibiótica. International Journal Morphology [Internet]. 2017 [Citado 03/11/2020];35(4):1214-23. Disponible en: https://scielo.conicyt.cl/scielo.php?pid=S0717-95022017000401214&script=sci_arttext&tlng=en
21. Franz RJ, Agustín SL. La farmacorresistencia microbiana: una nueva perspectiva. Revista OACTIVA UC-Cuenca [Internet]. 2019 [Citado 03/11/2020];4(3):[Aprox. 2 p.]. Disponible en: https://oactiva.ucacue.edu.ec/index.php/oactiva/article/view/396
22. Fariñas N. Resistencia bacteriana: un problema de salud pública mundial de difícil solución. Memorias del Instituto de Investigaciones en Ciencias de la Salud [Internet]. 2016 [Citado 12/11/2020];14(1):4-5. Disponible en: http://scielo.iics.una.py/scielo.php?pid=S1812-95282016000100001&script=sci_arttext
23. Cruz Martín LF. Resistencia bacteriana intrahospitalaria como problema ético en Colombia [Tesis de Especialidad]. Bogotá: Facultad de Ciencias-Pontificia Universidad Javeriana; 2020 [Citado 03/11/2020]. Disponible en: https://repository.javeriana.edu.co/handle/10554/50208
24. Sheu CC, Chang YT, Lin SY, Chen YH, Hsueh PR. Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options. Frontiers Microbiology [Internet]. 2019 [Citado 03/11/2020];10:80. Disponible en: https://www.frontiersin.org/articles/10.3389/fmicb.2019.00080/full
25. McConville TH, Sullivan SB, Gómez Simmonds A, Whittier S, Uhlemann A-C. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS One [Internet]. 2017 [Citado 03/11/2020];12(10):e0186195. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638409/
26. World Health Organization. Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level: interim practical manual supporting implementation of the Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities [Internet]. Geneva: World Health Organization; 2019 [Citado 03/11/2020]. Disponible en: https://apps.who.int/iris/handle/10665/312226
27. Oteo J. ¿Deben implantarse programas de cribado de cepas productoras de carbapenemasas en pacientes que ingresan en la UCI?. Enfermedades Infecciosas y Microbiología Clínica [Internet]. 2017 [Citado 03/11/2020];35(6):331-2. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0213005X16303858?via%3Dihub
28. Campillo Artero C, Ortún V. El análisis de coste-efectividad: por qué y cómo. Revista Española Cardiología [Internet]. 2016 [Citado 03/11/2020];69(4):370-3. Disponible en: https://www.revespcardiol.org/es-el-analisis-coste-efectividad-por-que-articulo-S0300893216000397
29. Ho KW, Ng WT, Ip M, You JH. Active surveillance of carbapenem-resistant Enterobacteriaceae in intensive care units: Is it cost-effective in a nonendemic region?. American Journal Infection Control [Internet]. 2016 [Citado 03/11/2020];44(4):394-9. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0196-6553(15)01112-8
30. You JHS, Li HK, Ip M. Surveillance-guided selective digestive decontamination of carbapenem-resistant Enterobacteriaceae in the intensive care unit: A cost-effectiveness analysis. American Journal Infection Control [Internet]. 2018 [Citado 03/11/2020];46(3):291-6. Disponible en: https://www.ajicjournal.org/article/S0196-6553(17)31054-4/fulltext
31. Lecuona Id. Ética médica: decisiones sobre el acceso de pacientes a UCI en situación de pandemia Asociación The Conversation [Internet]. España: Universitat de Barcelona; 2020 [Citado 03/11/2020]. Disponible en: http://diposit.ub.edu/dspace/handle/2445/155238
32. World Health Organization. Resistencia a los antimicrobianos [Internet]. Geneva: World Health Organization; 2020 [Citado 03/11/2020]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/antimicrobial-resistance
33. Macías Llanes ME, Figaredo Curiel F, Núñez Jover J, del Huerto Marimón ME. Los estudios sociales de la ciencia y la tecnología en la facultad cubana de oftalmología. Rev Cubana de Salud Pública [Internet]. 2008 [Citado 03/11/2020];34:[Aprox. 2 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662008000300010&nrm=iso
Download PDF
